The evolution of Pharma 4.0 integrates advanced technologies, transforming drug development and manufacturing with improved ...

Wave Life Sciences (WVE) said Takeda (TAK) has elected not to exercise its option to further develop its Huntington’s disease ...

The ABPI calls on Rachel Reeves to prioritise R&D investment in the coming Budget to unlock the potential of the UK life ...

Eli Lilly, which is defined as the largest pharma company by market cap, has signed a memorandum of understanding with the ...

The agreement will see MEDiC’s MCAT platform identify biomarkers to support the development of Hanmi’s clinical assets.

In pharmaceutical manufacturing, viscous drug products pose unique challenges to filling efficiency and accuracy.

This move underscores Mubadala’s commitment to supporting the UAE’s vision of becoming a global leader in the life sciences ...

The state has awarded Berkshire Sterile Manufacturing in Lee a $500,000 tax incentive to create 20 new jobs at its ...

Wave Life Sciences' WVE-006 study shows significant promise in treating alpha-1 antitrypsin deficiency. Learn more about WVE ...

The UK's world leading life sciences sector will receive a £279 million boost to tackle significant health challenges, with an intent expressed by ...

Eli Lilly’s senior VP of information and R&D IT, Ramesh Durvasula, said Lilly will use AI and tech to transform the company.

Mubadala Investment Company has empowered its new specialty pharmaceutical business, KELIX Bio, to acquire a 100 per cent ...